Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Niu XX"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low-level viraemia.
    Autorzy:
    Li ZB; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Li L; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Niu XX; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Chen SH; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Fu YM; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Wang CY; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Liu Y; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Shao Q; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Chen G; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Ji D; Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
    Pokaż więcej
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Jun; Vol. 41 (6), pp. 1254-1264. Date of Electronic Publication: 2021 Jan 19.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hepatitis B, Chronic*/drug therapy
    Adenine/analogs & derivatives ; Alanine ; Antiviral Agents/adverse effects ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Prospective Studies ; Tenofovir/analogs & derivatives ; Treatment Outcome ; Viremia/drug therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Water-soluble AIE-Active Fluorescent Organic Nanoparticles: Design, Preparation and Application for Specific Detection of Cysteine over Homocysteine and Glutathione in Living Cells.
    Autorzy:
    Ning ZW; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Wu SZ; The High School Affiliated to Renmin University of China, Beijing, 100080, China.
    Liu GJ; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Ji YM; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Jia LY; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Niu XX; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Ma RF; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Zhang Y; College of Chemistry, Beijing Normal University, Beijing, 100875, China.; Key Laboratory of Energy Conversion and Storage Materials, College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Xing GW; College of Chemistry, Beijing Normal University, Beijing, 100875, China.
    Pokaż więcej
    Źródło:
    Chemistry, an Asian journal [Chem Asian J] 2019 Jul 01; Vol. 14 (13), pp. 2220-2224. Date of Electronic Publication: 2019 Jun 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cysteine/*analysis
    Fluorescent Dyes/*chemistry
    Glutathione/*analysis
    Homocysteine/*analysis
    Nanoparticles/*chemistry
    Stilbenes/*chemistry
    Dimerization ; Hep G2 Cells ; Humans ; Microscopy, Confocal ; Nanoparticles/ultrastructure ; Optical Imaging ; Solubility ; Spectrometry, Fluorescence ; Water/chemistry
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
    Autorzy:
    Chen GF; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Wei L; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
    Chen J; Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.
    Duan ZP; The Translational Hepatology Institue, Beijing You'an Hospital, Capital University of Medicine, Beijing, China.
    Dou XG; Department of Infectious Diseases, Shengjing Hospital, China Medical University, Shenyang, China.
    Xie Q; Department of Infectious diseases, Shanghai Ruijin Hospital, Jiaotong University, School of Medicine, Shanghai, China.
    Zhang WH; Key Laboratory of Medical Molecular Virology, Huashan Hospital, Fudan University, Shanghai, China Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
    Lu LG; Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
    Fan JG; Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
    Cheng J; Liver Disease Center, Beijing Ditan Hospital, Capital University of Medicine, Beijing, China.
    Wang GQ; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
    Ren H; Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing, China.
    Wang JP; Department of Infectious Disease, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
    Yang XX; Department of Infection, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
    Jia ZS; Center of Diagnosis and Treatment for Infectious Diseases of Chinese PLA, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
    Fu QC; Shanghai Liver Diseases Research Center, Nanjing Military Command, Shanghai, China.
    Wang XJ; People's Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
    Shang J; Department of Infectious Diseases, Henan Provincal People's Hospital, Zhengzhou University, Zhengzhou, China.
    Zhang YX; Department of Infectious Disease, Xinjiang Medical University First Affiliated Hospital, Urumqi, China.
    Han Y; Department of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
    Du N; Liver Disease Center for Combined Traditional Chinese Medicine and Western Medicine, 302 Hospital, Beijing, China.
    Shao Q; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Ji D; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Li F; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Li B; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Liu JL; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Niu XX; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.
    Wang C; Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
    Wu V; Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.
    Wong A; Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.
    Wang YD; Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.
    Hou JL; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
    Jia JD; Liver Disease Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
    Zhuang H; Department of Microbiology and Center of Infectious Disease, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
    Lau G; Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, China.; Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Jun 08; Vol. 11 (6), pp. e0155934. Date of Electronic Publication: 2016 Jun 08 (Print Publication: 2016).
    Typ publikacji:
    Comparative Study; Evaluation Study; Journal Article
    MeSH Terms:
    Hepacivirus*
    Models, Economic*
    Benzimidazoles/*economics
    Fluorenes/*economics
    Hepatitis C/*economics
    Sofosbuvir/*economics
    Asian People ; Benzimidazoles/administration & dosage ; China/epidemiology ; Costs and Cost Analysis ; Female ; Fluorenes/administration & dosage ; Hepatitis C/drug therapy ; Hepatitis C/epidemiology ; Humans ; Male ; Markov Chains ; Sofosbuvir/administration & dosage
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    High survival of mouse oocytes using an optimized vitrification protocol.
    Autorzy:
    Zhou CJ; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Wang DH; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Niu XX; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Kong XW; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Li YJ; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Ren J; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Zhou HX; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Lu A; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Zhao YF; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Liang CG; The Key Laboratory of National Education, Ministry for Mammalian Reproductive Biology and Biotechnology, Inner Mongolia University, Hohhot, Inner Mongolia, People's Republic of China.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Jan 19; Vol. 6, pp. 19465. Date of Electronic Publication: 2016 Jan 19.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cell Survival/*drug effects
    Cryopreservation/*methods
    Cryoprotective Agents/*pharmacology
    Oocytes/*cytology
    Animals ; Blastocyst/drug effects ; Blastocyst/physiology ; Cell Survival/physiology ; Dimethyl Sulfoxide/pharmacology ; Embryonic Development/drug effects ; Embryonic Development/physiology ; Ethylene Glycol/pharmacology ; Female ; Fertilization/drug effects ; Fertilization/physiology ; Fertilization in Vitro/drug effects ; Fertilization in Vitro/methods ; Male ; Mice ; Vitrification
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies